Drug Shortage Report for ALOMIDE
Report ID | 52770 |
Drug Identification Number | 00893560 |
Brand name | ALOMIDE |
Common or Proper name | ALOMIDE SOLUTION 10ML |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | LODOXAMIDE |
Strength(s) | 0.1% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 10 ML |
ATC code | S01GX |
ATC description | DECONGESTANTS AND ANTIALLERGICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2018-06-22 |
Actual start date | 2018-06-22 |
Estimated end date | 2018-07-31 |
Actual end date | 2018-07-26 |
Shortage status | Resolved |
Updated date | 2018-07-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-06-22 | English | Compare |
v2 | 2018-06-22 | English | Compare |
v3 | 2018-06-22 | English | Compare |
v4 | 2018-06-22 | French | Compare |
v5 | 2018-06-23 | English | Compare |
v6 | 2018-07-05 | English | Compare |
v7 | 2018-07-05 | French | Compare |
v8 | 2018-07-27 | English | Compare |
v9 | 2018-07-27 | French | Compare |
Showing 1 to 9 of 9